24 July 2018 (Tuesday) - Anti-CD38 therapies
Here’s something interesting which came up in the Facebook Blood Bank Interest Group:
Daratumumab is something of which I’ve heard. Its anti CD38 makes it something of a pain in the blood bank. It would seem there’s several other drugs which work in the same sort of way.
The subsequent discussion on the post was interesting: I particularly found one paper rather relevant:
Labels: Blood Bank Interest Group